Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012324

Director sold 400,000 shares at $1.00 ($400,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Javitt Jonathan C Director 2022-12-07 Sale −400,000 $1.00 $400,000 12,899,997 I
Open-market sales · 400,000 sh · avg $1.00 · $400,000
Loading xslF345X03/form4-12092022_091256.xml…